Your browser doesn't support javascript.
loading
HCN Channel Activity Balances Quiescence and Proliferation in Neural Stem Cells and Is a Selective Target for Neuroprotection During Cancer Treatment.
Johard, Helena; Omelyanenko, Anna; Fei, Gao; Zilberter, Misha; Dave, Zankruti; Abu-Youssef, Randa; Schmidt, Linnéa; Harisankar, Aditya; Vincent, C Theresa; Walfridsson, Julian; Nelander, Sven; Harkany, Tibor; Blomgren, Klas; Andäng, Michael.
Affiliation
  • Johard H; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Omelyanenko A; Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.
  • Fei G; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Zilberter M; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Dave Z; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Abu-Youssef R; College of Veterinary Medicine, Jilin University, Changchun, Jilin, China.
  • Schmidt L; Gladstone Institute of Neurological Disease, San Francisco, California.
  • Harisankar A; Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.
  • Vincent CT; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Walfridsson J; Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.
  • Nelander S; Department of Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Harkany T; Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.
  • Blomgren K; Department of Microbiology, New York University School of Medicine, New York, New York.
  • Andäng M; Department of Medicine, Karolinska Institutet, Huddinge, Sweden.
Mol Cancer Res ; 18(10): 1522-1533, 2020 10.
Article in En | MEDLINE | ID: mdl-32665429
Children suffering from neurologic cancers undergoing chemotherapy and radiotherapy are at high risk of reduced neurocognitive abilities likely via damage to proliferating neural stem cells (NSC). Therefore, strategies to protect NSCs are needed. We argue that induced cell-cycle arrest/quiescence in NSCs during cancer treatment can represent such a strategy. Here, we show that hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channels are dynamically expressed over the cell cycle in NSCs, depolarize the membrane potential, underlie spontaneous calcium oscillations and are required to maintain NSCs in the actively proliferating pool. Hyperpolarizing pharmacologic inhibition of HCN channels during exposure to ionizing radiation protects NSCs cells in neurogenic brain regions of young mice. In contrast, brain tumor-initiating cells, which also express HCN channels, remain proliferative during HCN inhibition. IMPLICATIONS: Our finding that NSCs can be selectively rescued while cancer cells remain sensitive to the treatment, provide a foundation for reduction of cognitive impairment in children with neurologic cancers.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neural Stem Cells / Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels / Neoplasms Limits: Animals / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Sweden Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neural Stem Cells / Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels / Neoplasms Limits: Animals / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Sweden Country of publication: United States